AO
About
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipeline in oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 118 investors are based in Suzhou, Jiangsu, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Suzhou, China
Contact Information
linkedin.com/in/••••••••
Find more investors like Alphamab
Search Investors